×

PAVmed Inc. (Nasdaq: PAVMU) to Ring The Nasdaq Stock Market Opening Bell

ADVISORY, April 28, 2016 (GLOBE NEWSWIRE) --

What:
PAVmed Inc. (Nasdaq:PAVMU), a multi-product medical device company bringing innovative medical technologies from concept to commercialization with unprecedented speed and capital efficiency, will visit the Nasdaq MarketSite in Times Square to celebrate its recent initial public offering (IPO) on April 28, 2016.

In honor of the occasion, Lishan Aklog, Chairman and Chief Executive Officer, will ring the Opening Bell.

Where:
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When:
Friday, April 29, 2016 – 9:15 a.m. to 9:30 a.m. ET

PAVmed Media Contact:
Erich Sandoval
(917) 497-2867
esandoval@lazarpartners.com

Nasdaq MarketSite:
Emily Pan
(646) 441-5120
emily.pan@nasdaq.com

Feed Information:
Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK

Social Media:
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page:
http://www.facebook.com/NASDAQ.

For photos from ceremonies and events, please visit our Instagram page:
http://instagram.com/nasdaq

For livestream of ceremonies and events, please visit our YouTube page:
http://www.youtube.com/nasdaq/live

For news tweets, please visit our Twitter page:
http://twitter.com/nasdaq

For exciting viral content and ceremony photos, please visit our Tumblr page:
http://nasdaq.tumblr.com/

Webcast:
A live stream of the Nasdaq Opening Bell will be available at:
https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx

Photos:
To obtain a hi-resolution photograph of the Market Open, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market open of your choice.

About PAVmed
PAVmed is a groundbreaking multi-product medical device company bringing innovative medical technologies from concept to commercialization with unprecedented speed and capital efficiency. PAVmed was founded and is led by three successful medical device entrepreneurs. Dr. Lishan Aklog and Dr. Brian deGuzman are prominent Harvard-trained cardiothoracic surgeons and leaders in medical device innovation. Michael Glennon is a medical device industry veteran and former senior executive at the market leader in outsourced medical device manufacturing.

PAVmed is built on a disruptive business model conceived, deployed and refined by its principals. Over the past six years, this team has used its unique business model focused on capital efficiency and speed to market to build four successful medical device companies, Vortex Medical, Saphena Medical, Cruzar Medsystems, and Kaleidoscope Medical, each funded with a modest single round of venture capital ($1.4 to $3.5 million). Their first company, Vortex Medical, commercialized its revolutionary AngioVac® a mere eighteen months after its inception and was eventually sold to Angiodynamics (Nasdaq:ANGO) for $55+ million. Saphena Medical commercialized its Venapax® next generation endoscopic vessel harvesting device in eighteen months which is poised to capture significant market share and dramatically enhance its value, and is marketing its third-generation device across the United States. Cruzar Medsystems recently received FDA clearance of its novel Houdini® chronic vascular occlusion device and will launch commercially next month. Finally, Kaleidoscope Medical’s novel reversible inferior vena cava filter is at the FDA.

PAVmed's principals have now created PAVmed as a long-term vehicle, armed with permanent capital, to expand the impact of their model to a broader and deeper pipeline and accelerate value creation in the process. PAVmed is building a deep development pipeline with products with attractive regulatory pathways and market opportunities encompassing a broad spectrum of clinical areas including cardiovascular care, tissue ablation, medical infusions, hand surgery and laparoscopic surgery. It is further expanding its pipeline through engagements with clinician inventors and leading academic medical centers.

About Nasdaq
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of approximately $9.3 trillion and nearly 17,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.

-NDAQA-

Source:NASDAQ, Inc.